REG - Irish Takeover Panel - Disclosure Table

Xoma RoyaltyAnnouncement

14/11/2025 11:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251114:nRSN6135Ha&default-theme=true

RNS Number : 6135H  Irish Takeover Panel  14 November 2025

IRISH TAKEOVER PANEL
 
Disclosure Table
 

The following companies are deemed to be in an offer period for the purposes
of disclosure under the Rules of the Irish Takeover Panel:

_______________________________________________________________

Offeree:          Mural Oncology plc

Offer period commenced:  15 April 2025

$0.01 ordinary shares; ISIN: IE000LK2BOB4; NSI: 17,268,881

Offeror:          XOMA Royalty Corporation

Disclosure of dealings and positions in this offeror is not required

Offeror identified: 20 August 2025

Rule 2.6(a) deadline: N/A

 

Offeree:          Avadel Pharmaceuticals plc

Offer period commenced:  22 October 2025

$0.01 ordinary shares; ISIN: IE00BDGMC594; NSI: 97,403,364

Offeror:          Alkermes plc

Disclosure of dealings and positions in this offeror is not required

Offeror identified: 22 October 2025

Rule 2.6(a) deadline: N/A

 

Offeree:          Permanent TSB Group Holdings plc

Offer period commenced:  30 October 2025

€0.01 ordinary shares; ISIN: IE00BWB8X525; NSI: 544,996,176

Offeror:          N/A

Offeror identified: N/A

Rule 2.6(a) deadline: N/A

 

 

Irish Takeover
Panel
14 November 2025

Lower Ground Floor

76 Merrion Square

Dublin D02 X4T1

 

Telephone:    + 353-1-678
9020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISEBGBDBDGBDGUS



            Copyright 2019 Regulatory News Service, all rights reserved